Biopharma Conference
Pierre Fabre Virtual Biopharma Partnering 2022
Virtual Private Partnering Event March 14-16, 2022
Second edition of an exclusive on-line event with Pierre Fabre’s Executive Management.
From 14th to 16th March, we will be hosting an on-line partnering event composed of virtual face-to-face meetings with Pierre Fabre scheduled via the One-on-One Partnering™ platform provided by Inova.
Pierre Fabre will be represented by members of our Executive Management team and our Corporate Business Development & Licensing team.
The Executive Management Team at Pierre Fabre is pleased to invite prospective partners to the second edition of our custom and exclusive on-line event. We are reaching out to innovative biopharmaceutical companies developing new therapies in the areas of oncology, dermatology and rare diseases, and looking for a partner with a global presence. Proposals for partnerships leveraging our commercial capabilities in Europe in the areas of urology, rheumatology, and gynaecology/women’s health will also be welcome. The mission of The Pierre Fabre Group for over fifty years has been to develop innovative products and solutions that make significant contributions to the health and well-being of men and women all over the world, making a positive impact on their daily life.
Pierre Fabre Virtual Biopharma Partnering 2022 is powered by One-on-One Partnering™
Inova develops the One-on-One Partnering™ platform of Pierre Fabre Virtual Biopharma Partnering 2022. It’s a smart networking tool to find the right partners and schedule face-to-face meetings at Pierre Fabre Virtual Biopharma Partnering 2022 and +20 other partnering conferences.
This conference is connected to Inova’s partnering platform
One-on-One Partnering™ is a smart networking tool to schedule face-to-face meetings at partnering conferences. Since Pierre Fabre Virtual Biopharma Partnering 2022 is using the solution we built, it’s easy for us to connect our products and thus you can easily retrieve all your conference meetings directly in Inova.
